Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001193125-26-052020

General Counsel and Secretary gave up 2,502 shares (to pay taxes)

  • General Counsel and Secretary acquired 6,075 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Samuel George A. III · General Counsel and Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-11 Exercise or conversion : show line 1 in the form +6,075 33,565 D
2026-02-11 Shares withheld for taxes : show line 2 in the form −2,502 $1.80 $4,504 31,063 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-11 Exercise or conversion : show line 3 in the form Restricted Stock Units −6,075 0 D
Loading xslF345X05/ownership.xml…